Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 7
1988 3
1989 4
1990 2
1991 8
1992 3
1993 5
1994 2
1995 3
1996 2
1997 3
1999 7
2000 1
2001 2
2002 4
2003 1
2004 1
2005 4
2006 4
2007 1
2008 2
2009 2
2010 3
2011 5
2012 2
2013 5
2014 6
2015 9
2016 10
2017 8
2018 3
2019 6
2020 9
2021 5
2022 4
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Results by year

Filters applied: . Clear all
Page 1
GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial.
Capone S, Fusco FM, Milleri S, Borrè S, Carbonara S, Lo Caputo S, Leone S, Gori G, Maggi P, Cascio A, Lichtner M, Cauda R, Dal Zoppo S, Cossu MV, Gori A, Roda S, Confalonieri P, Bonora S, Missale G, Codeluppi M, Mezzaroma I, Capici S, Pontali E, Libanore M, Diani A, Lanini S, Battella S, Contino AM, Piano Mortari E, Genova F, Parente G, Dragonetti R, Colloca S, Visani L, Iannacone C, Carsetti R, Folgori A, Camerini R; COVITAR study group. Capone S, et al. Among authors: mezzaroma i. Cell Rep Med. 2023 Jun 20;4(6):101084. doi: 10.1016/j.xcrm.2023.101084. Epub 2023 May 29. Cell Rep Med. 2023. PMID: 37315558 Free PMC article. Clinical Trial.
Dolutegravir: clinical efficacy and role in HIV therapy.
Fantauzzi A, Mezzaroma I. Fantauzzi A, et al. Among authors: mezzaroma i. Ther Adv Chronic Dis. 2014 Jul;5(4):164-77. doi: 10.1177/2040622314530461. Ther Adv Chronic Dis. 2014. PMID: 24982751 Free PMC article. Review.
Immune Reconstitution and Safe Metabolic Profile after the Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate among Virologically Controlled PLWH: A 96 Week Update from the BICTEL Cohort.
Lazzaro A, Bianchini D, Gentilini Cacciola E, Mezzaroma I, Falciano M, Andreoni C, Fimiani C, Santinelli L, Maddaloni L, Bugani G, Ceccarelli G, Mastroianni CM, d'Ettorre G. Lazzaro A, et al. Among authors: mezzaroma i. Viruses. 2023 May 23;15(6):1222. doi: 10.3390/v15061222. Viruses. 2023. PMID: 37376522 Free PMC article.
Immunodysregulation of HIV disease at bone marrow level.
Isgrò A, Aiuti A, Leti W, Gramiccioni C, Esposito A, Mezzaroma I, Aiuti F. Isgrò A, et al. Among authors: mezzaroma i. Autoimmun Rev. 2005 Nov;4(8):486-90. doi: 10.1016/j.autrev.2005.04.014. Autoimmun Rev. 2005. PMID: 16214083 Review.
Reduced Plasma Levels of sCD14 and I-FABP in HIV-infected Patients with Mesalazine-treated Ulcerative Colitis.
Michelini Z, Baroncelli S, Fantauzzi A, Pasquale C, Galluzzo CM, Sanchez M, Gatto M, Amici R, Franco M, d'Ettorre G, Fimiani C, Mezzaroma I, Vullo V, Merli M, Palmisano L. Michelini Z, et al. Among authors: mezzaroma i. HIV Clin Trials. 2016 Mar;17(2):49-54. doi: 10.1080/15284336.2015.1125077. Epub 2016 Jan 7. HIV Clin Trials. 2016. PMID: 26739837 Clinical Trial.
Silent HIV infection.
Aiuti F, Ensoli F, Fiorelli V, Mezzaroma I, Pinter E, Guerra E, Varani AR. Aiuti F, et al. Among authors: mezzaroma i. Vaccine. 1993;11(5):538-41. doi: 10.1016/0264-410x(93)90226-n. Vaccine. 1993. PMID: 8488706
Th2-type cytokines, hypereosinophilia, and interleukin-5 in HIV disease.
Paganelli R, Scala E, Mazzone AM, Rosso R, Mattiacci G, Dell'Anna L, Mezzaroma I, Aiuti F. Paganelli R, et al. Among authors: mezzaroma i. Allergy. 1997 Jan;52(1):110-1. doi: 10.1111/j.1398-9995.1997.tb02555.x. Allergy. 1997. PMID: 9062639 Review. No abstract available.
141 results